AzTrials
AzTrials

Country

Clinical Trials in Morocco

Studies with at least one site in Morocco. Open a trial for its sites in Morocco, who to contact and who can take part.

180 registered studies

In numbers

Open to volunteers
19
Active
25
With results posted
51
All registered
180

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 19
  • Frail Elderly, Frailty

    Frailty Training for Emergency Nurses: A Cluster RCT in Morocco

    • Recruiting
    • Age: All ages

    This study tests whether a training program helps nurses better recognize and care for older adults with frailty in hospital emergency departments.

    Trial name
    NCT07892612
    Testing
    Structured Educational Program on Geriatric Frailty
    Where
    Morocco
    Volunteers
    144 people
    Sponsor
    Cadi Ayyad University
    Can I take part? NCT07892612
  • Cerebral Venous Sinus Thrombosis

    MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

    • Recruiting
    • Age: 18 to 65 years
    • Pill or oral medicine
    • Injection or infusion

    REVIVE-CVST is a multicenter, prospective, randomized, open-label, blinded-endpoint (PROBE) trial evaluating whether early endovascular thrombectomy (EVT) combined with standard anticoagulation improves outcomes compared to…

    Trial name
    REVIVE-CVST (NCT07548346)
    Testing
    Endovascular Thrombectomy, Anticoagulation Therapy
    Where
    14 sites in Egypt, Jordan and 6 more
    Volunteers
    440 people
    Sponsor
    Middle East North Africa Stroke and Interventional Neurotherapies Organization
    Can I take part? REVIVE-CVST
  • HepatoCellular Carcinoma

    CHARM Hepatocellular Carcinoma MEA Study

    • Recruiting
    • Age: All ages
    • Observational study

    Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer and the third reason for cancer-related death worldwide.

    Trial name
    NCT07650773
    Where
    17 sites in Egypt, Kuwait and 5 more
    Volunteers
    4,000 people
    Sponsor
    AstraZeneca
    Can I take part? NCT07650773
  • Benign Prostatic Hyperplasia, Transurethral Resection of the Prostate

    Tranexamic Acid for Bleeding Reduction During TURP Surgery

    • Recruiting
    • Age: 50 years and older
    • Phase 4
    • Injection or infusion

    Transurethral resection of the prostate (TURP) is commonly performed in elderly patients and may be associated with perioperative bleeding leading to postoperative anemia and delayed recovery.

    Conditions
    Benign Prostatic Hyperplasia, Transurethral Resection of the Prostate, Perioperative Bleeding, Anemia, Postoperative
    Trial name
    TXA-TURP (NCT07460518)
    Testing
    Tranexamic Acid
    Where
    Morocco
    Volunteers
    80 people
    Sponsor
    Hamza Najout
    Can I take part? TXA-TURP
  • Age, Residency

    The Effect of Audio-hypnosis on the Academic Performance of Nursing Students.

    • Not yet recruiting
    • Age: All ages
    • Lifestyle or therapy programme

    Exam stress significantly affects the mental health and cognitive functions of nursing students. Audio-hypnosis offers a practical and low-cost intervention.

    Conditions
    Age, Residency, Gender, Stress
    Trial name
    Hypnoacademic (NCT07823647)
    Testing
    Audio hypnosis
    Where
    Morocco
    Volunteers
    20 people, healthy volunteers welcome
    Sponsor
    HASSAN 1st university
  • Hematology, Diffused Large B Cell Lymphoma

    A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region

    • Recruiting
    • Age: All ages
    • Observational study

    Non-Hodgkin lymphoma (NHL) is the most common hematologic malignancy, with over 80,500 estimated new cases diagnosed in the United States in 20231.

    Trial name
    DOMAIN (NCT07065344)
    Where
    21 sites in Egypt, Iraq and 8 more
    Volunteers
    500 people
    Sponsor
    AstraZeneca
    Can I take part? DOMAIN
  • Venous Thromboembolism

    Computerized Registry of Patients With Venous Thromboembolism (RIETE)

    • Recruiting
    • Age: All ages
    • Observational study

    The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous…

    Trial name
    RIETE (NCT02832245)
    Where
    305 sites in United States, Argentina and 27 more
    Volunteers
    120,000 people
    Sponsor
    Manuel Monreal
    Can I take part? RIETE
  • Cancer (Solid Tumors), Interaction Drug Food

    Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential Drug Interactions

    • Recruiting
    • Age: 18 years and older
    • Observational study
    • Lifestyle or therapy programme

    The goal of this observational study is to To assess the prevalence and patterns of dietary supplement use among patients with cancer and to analyze the impact of these supplements in the context of anticancer medical treatments…

    Trial name
    Dietary Supple (NCT07670234)
    Testing
    Dietary Supplement Use Assessment
    Where
    Morocco
    Volunteers
    1,000 people
    Sponsor
    Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI)
  • Carotid Stenosis

    Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque

    • Not yet recruiting
    • Age: 40 to 80 years
    • Phase 3
    • Pill or oral medicine
    • Injection or infusion

    CAROTID-STABILISE is a phase III, multicentre, randomised, double-blind, placebo-controlled trial evaluating whether alirocumab 150 mg subcutaneously every 2 weeks, added to high-intensity statin therapy, produces greater…

    Trial name
    CAROTID-STABIL (NCT07586540)
    Testing
    Alirocumab, Atorvastatin
    Where
    14 sites in Egypt, Jordan and 6 more
    Volunteers
    280 people
    Sponsor
    Middle East North Africa Stroke and Interventional Neurotherapies Organization
  • Depression - Major Depressive Disorder

    Pharmacogenetic-Guided Antidepressant Treatment in Depression

    • Not yet recruiting
    • Age: 18 years and older

    The purpose of this clinical trial is to evaluate whether using pharmacogenetic testing to guide antidepressant treatment can improve outcomes in adults with major depressive disorder in Morocco.

    Trial name
    PGX-MDD (NCT07480486)
    Testing
    Pharmacogenetic-Guided Treatment, Usual Care
    Where
    Morocco
    Volunteers
    570 people
    Sponsor
    Mohammed V University in Rabat
    Can I take part? PGX-MDD

Completed, with results posted

All –

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in